- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Market Overview
The global mRNA Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The mRNA Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
mRNA Vaccine market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, mRNA Vaccine market has been segmented into Standardization Of Cancer Treatment MRNA Vaccine, Individualized Cancer Treatment MRNA Vaccine, Infectious Disease Treatment MRNA Vaccine, Infection Prevention MRNA Vaccine, etc.
Breakdown by Application, mRNA Vaccine has been segmented into Infectious Disease, Cancer, Other, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global mRNA Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level mRNA Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global mRNA Vaccine market.
For China, this report analyses the China market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and mRNA Vaccine Market Share Analysis
mRNA Vaccine competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, mRNA Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the mRNA Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in mRNA Vaccine are: Moderna Therapeutics, eTheRNA, BioNTech, CureVac, In-Cell-Art, Translate Bio, Tiba Biotechnology, Argos Therapeutics, Sangamo Therapeutics, Ethris, etc. Among other players domestic and global, mRNA Vaccine market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The key market players for global mRNA Vaccine market are listed below:
Moderna Therapeutics
eTheRNA
BioNTech
CureVac
In-Cell-Art
Translate Bio
Tiba Biotechnology
Argos Therapeutics
Sangamo Therapeutics
Ethris
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)
Market segment by Type, covers:
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
Market segment by Application, can be divided into
Infectious Disease
Cancer
Other
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 mRNA Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global mRNA Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Standardization Of Cancer Treatment MRNA Vaccine
1.2.3 Individualized Cancer Treatment MRNA Vaccine
1.2.4 Infectious Disease Treatment MRNA Vaccine
1.2.5 Infection Prevention MRNA Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global mRNA Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Other
1.4 Global mRNA Vaccine Market Size and Forecast (2015-2025)
1.4.1 Global mRNA Vaccine Revenue and Forecast (2015-2025)
1.4.2 Global mRNA Vaccine Sales and Forecast (2015-2025)
1.5 Global mRNA Vaccine Market Size Overview by Geography (2015-2020)
2 Manufacturers Profiles
2.1 Moderna Therapeutics
2.1.1 Moderna Therapeutics Details
2.1.2 Moderna Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Moderna Therapeutics SWOT Analysis
2.1.4 Moderna Therapeutics Product and Services
2.1.5 Moderna Therapeutics mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 eTheRNA
2.2.1 eTheRNA Details
2.2.2 eTheRNA Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 eTheRNA SWOT Analysis
2.2.4 eTheRNA Product and Services
2.2.5 eTheRNA mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 BioNTech
2.3.1 BioNTech Details
2.3.2 BioNTech Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 BioNTech SWOT Analysis
2.3.4 BioNTech Product and Services
2.3.5 BioNTech mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 CureVac
2.4.1 CureVac Details
2.4.2 CureVac Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 CureVac SWOT Analysis
2.4.4 CureVac Product and Services
2.4.5 CureVac mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 In-Cell-Art
2.5.1 In-Cell-Art Details
2.5.2 In-Cell-Art Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 In-Cell-Art SWOT Analysis
2.5.4 In-Cell-Art Product and Services
2.5.5 In-Cell-Art mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Translate Bio
2.6.1 Translate Bio Details
2.6.2 Translate Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Translate Bio SWOT Analysis
2.6.4 Translate Bio Product and Services
2.6.5 Translate Bio mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Tiba Biotechnology
2.7.1 Tiba Biotechnology Details
2.7.2 Tiba Biotechnology Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Tiba Biotechnology SWOT Analysis
2.7.4 Tiba Biotechnology Product and Services
2.7.5 Tiba Biotechnology mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Argos Therapeutics
2.8.1 Argos Therapeutics Details
2.8.2 Argos Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Argos Therapeutics SWOT Analysis
2.8.4 Argos Therapeutics Product and Services
2.8.5 Argos Therapeutics mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sangamo Therapeutics
2.9.1 Sangamo Therapeutics Details
2.9.2 Sangamo Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Sangamo Therapeutics SWOT Analysis
2.9.4 Sangamo Therapeutics Product and Services
2.9.5 Sangamo Therapeutics mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Ethris
2.10.1 Ethris Details
2.10.2 Ethris Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Ethris SWOT Analysis
2.10.4 Ethris Product and Services
2.10.5 Ethris mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Global mRNA Vaccine Market, Company Landscape
3.1 Company Market Share Analysis: Global
3.1.1 Global mRNA Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.1.2 Global mRNA Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.2 Company Market Share Analysis: China
3.2.1 Key Players mRNA Vaccine Sales in China (2018-2019)
3.2.2 China mRNA Vaccine Revenue Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 mRNA Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 mRNA Vaccine Manufacturer Market Share in 2019
4 Market Size by Geography
4.1 Global mRNA Vaccine Market Size by Geography (2015-2020)
4.1.1 Global mRNA Vaccine Sales by Geography (2015-2020)
4.1.2 Global mRNA Vaccine Revenue by Regions (2015-2020)
4.2 Global mRNA Vaccine Market Size and Forecast by Regions (2020-2025)
4.2.1 Global mRNA Vaccine Sales and Forecast by Regions (2020-2025)
4.2.2 Global mRNA Vaccine Revenue and Forecast by Regions (2020-2025)
4.3 North America mRNA Vaccine Market Size and Forecast (2015-2025)
4.4 Europe mRNA Vaccine Market Size and Forecast (2015-2025)
4.5 Asia-Pacific mRNA Vaccine Market Size and Forecast (2015-2025)
4.6 South America mRNA Vaccine Market Size and Forecast (2015-2025)
4.7 Middle East and Africa mRNA Vaccine Market Size and Forecast (2015-2025)
5 North America by Country
5.1 North America mRNA Vaccine Market Size by Country (2015-2020)
5.1.1 North America mRNA Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America mRNA Vaccine Revenue and Market Share by Country (2015-2020)
5.2 North America mRNA Vaccine Market Size and Forecast by Country (2020-2025)
5.2.1 North America mRNA Vaccine Sales and Forecast by Country (2020-2025)
5.2.2 North America mRNA Vaccine Revenue and Forecast by Country (2020-2025)
5.3 United States mRNA Vaccine Market Size and Forecast (2015-2025)
5.4 Canada mRNA Vaccine Market Size and Forecast (2015-2025)
5.5 Mexico mRNA Vaccine Market Size and Forecast (2015-2025)
6 Europe by Country
6.1 Europe mRNA Vaccine Market Size by Country (2015-2020)
6.1.1 Europe mRNA Vaccine Sales by Country (2015-2020)
6.1.2 Europe mRNA Vaccine Revenue by Country (2015-2020)
6.2 Europe mRNA Vaccine Market Size and Forecast by Country (2020-2025)
6.2.1 Europe mRNA Vaccine Sales and Forecast by Country (2020-2025)
6.2.2 Europe mRNA Vaccine Revenue and Forecast by Country (2020-2025)
6.3 Germany mRNA Vaccine Market Size and Forecast (2015-2025)
6.4 United Kingdom mRNA Vaccine Market Size and Forecast (2015-2025)
6.5 France mRNA Vaccine Market Size and Forecast (2015-2025)
6.6 Russia mRNA Vaccine Market Size and Forecast (2015-2025)
6.7 Italy mRNA Vaccine Market Size and Forecast (2015-2025)
7 Asia-Pacific by Regions
7.1 Asia-Pacific mRNA Vaccine Market Size by Region (2015-2020)
7.1.1 Asia-Pacific mRNA Vaccine Sales by Region (2015-2020)
7.1.2 Asia-Pacific mRNA Vaccine Revenue by Region (2015-2020)
7.2 Asia-Pacific mRNA Vaccine Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific mRNA Vaccine Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific mRNA Vaccine Revenue and Forecast by Region (2020-2025)
7.3 China mRNA Vaccine Market Size and Forecast (2015-2025)
7.4 Japan mRNA Vaccine Market Size and Forecast (2015-2025)
7.5 Korea mRNA Vaccine Market Size and Forecast (2015-2025)
7.6 India mRNA Vaccine Market Size and Forecast (2015-2025)
7.7 Southeast Asia mRNA Vaccine Market Size and Forecast (2015-2025)
7.8 Australia mRNA Vaccine Market Size and Forecast (2015-2025)
8 South America by Country
8.1 South America mRNA Vaccine Market Size by Country (2015-2020)
8.1.1 South America mRNA Vaccine Sales by Country (2015-2020)
8.1.2 South America mRNA Vaccine Revenue by Country (2015-2020)
8.2 South America mRNA Vaccine Market Size and Forecast by Country (2020-2025)
8.2.1 South America mRNA Vaccine Sales and Forecast by Country (2020-2025)
8.2.2 South America mRNA Vaccine Revenue and Forecast by Country (2020-2025)
8.3 Brazil mRNA Vaccine Market Size and Forecast (2015-2025)
8.4 Argentina mRNA Vaccine Market Size and Forecast (2015-2025)
9 Middle East & Africa by Countries
9.1 Middle East & Africa mRNA Vaccine Market Size by Country (2015-2020)
9.1.1 Middle East & Africa mRNA Vaccine Sales by Country (2015-2020)
9.1.2 Middle East & Africa mRNA Vaccine Revenue by Country (2015-2020)
9.2 Middle East & Africa mRNA Vaccine Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East & Africa mRNA Vaccine Sales and Forecast by Country (2020-2025)
9.2.2 Middle East & Africa mRNA Vaccine Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia mRNA Vaccine Market Size and Forecast (2015-2025)
9.4 Turkey mRNA Vaccine Market Size and Forecast (2015-2025)
9.5 Egypt mRNA Vaccine Market Size and Forecast (2015-2025)
9.6 South Africa mRNA Vaccine Market Size and Forecast (2015-2025)
10 Market Segment by Type
10.1 Global mRNA Vaccine Market Size by Type (2015-2020)
10.1.1 Global mRNA Vaccine Sales by Type (2015-2020)
10.1.2 Global mRNA Vaccine Revenue by Type (2015-2020)
10.1.3 Global mRNA Vaccine Price by Type (2015-2020)
10.2 Global mRNA Vaccine Market Size and Forecast by Type (2020-2025)
10.2.1 Global mRNA Vaccine Sales and Forecast by Type (2020-2025)
10.2.2 Global mRNA Vaccine Revenue and Forecast by Type (2020-2025)
10.2.3 Global mRNA Vaccine Price and Forecast by Type (2020-2025)
10.3 China mRNA Vaccine Market Size and Forecast by Type (2015-2025)
10.3.1 China mRNA Vaccine Market Size by Type (2015-2020)
10.3.2 China mRNA Vaccine Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global mRNA Vaccine Market Size by Application (2015-2020)
11.1.1 Global mRNA Vaccine Sales by Application (2015-2020)
11.1.2 Global mRNA Vaccine Revenue by Application (2015-2020)
11.1.3 Global mRNA Vaccine Price by Application (2015-2020)
11.2 Global mRNA Vaccine Market Size and Forecast by Application (2020-2025)
11.2.1 Global mRNA Vaccine Sales and Forecast by Application (2020-2025)
11.2.2 Global mRNA Vaccine Revenue and Forecast by Application (2020-2025)
11.2.3 Global mRNA Vaccine Price and Forecast by Application (2020-2025)
11.3 China mRNA Vaccine Market Size and Forecast by Application (2015-2025)
11.3.1 China mRNA Vaccine Market Size by Application (2015-2020)
11.3.2 China mRNA Vaccine Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global mRNA Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of mRNA Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global mRNA Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global mRNA Vaccine Market Size Overview by Geography (2015-2020) (USD Million)
Table 5. Moderna Therapeutics Basic Information, Manufacturing Base and Competitors
Table 6. Moderna Therapeutics mRNA Vaccine Major Business
Table 7. Moderna Therapeutics mRNA Vaccine Total Revenue (USD Million) (2018-2019)
Table 8. Moderna Therapeutics SWOT Analysis
Table 9. Moderna Therapeutics mRNA Vaccine Product and Services
Table 10. Moderna Therapeutics mRNA Vaccine Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 11. eTheRNA Basic Information, Manufacturing Base and Competitors
Table 12. eTheRNA mRNA Vaccine Major Business
Table 13. eTheRNA mRNA Vaccine Total Revenue (USD Million) (2018-2019)
Table 14. eTheRNA SWOT Analysis
Table 15. eTheRNA mRNA Vaccine Product and Services
Table 16. eTheRNA mRNA Vaccine Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 17. BioNTech Basic Information, Manufacturing Base and Competitors
Table 18. BioNTech mRNA Vaccine Major Business
Table 19. BioNTech mRNA Vaccine Total Revenue (USD Million) (2018-2019)
Table 20. BioNTech SWOT Analysis
Table 21. BioNTech mRNA Vaccine Product and Services
Table 22. BioNTech mRNA Vaccine Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 23. CureVac Basic Information, Manufacturing Base and Competitors
Table 24. CureVac mRNA Vaccine Major Business
Table 25. CureVac mRNA Vaccine Total Revenue (USD Million) (2018-2019)
Table 26. CureVac SWOT Analysis
Table 27. CureVac mRNA Vaccine Product and Services
Table 28. CureVac mRNA Vaccine Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 29. In-Cell-Art Basic Information, Manufacturing Base and Competitors
Table 30. In-Cell-Art mRNA Vaccine Major Business
Table 31. In-Cell-Art mRNA Vaccine Total Revenue (USD Million) (2018-2019)
Table 32. In-Cell-Art SWOT Analysis
Table 33. In-Cell-Art mRNA Vaccine Product and Services
Table 34. In-Cell-Art mRNA Vaccine Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 35. Translate Bio Basic Information, Manufacturing Base and Competitors
Table 36. Translate Bio mRNA Vaccine Major Business
Table 37. Translate Bio mRNA Vaccine Total Revenue (USD Million) (2018-2019)
Table 38. Translate Bio SWOT Analysis
Table 39. Translate Bio mRNA Vaccine Product and Services
Table 40. Translate Bio mRNA Vaccine Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 41. Tiba Biotechnology Basic Information, Manufacturing Base and Competitors
Table 42. Tiba Biotechnology mRNA Vaccine Major Business
Table 43. Tiba Biotechnology mRNA Vaccine Total Revenue (USD Million) (2018-2019)
Table 44. Tiba Biotechnology SWOT Analysis
Table 45. Tiba Biotechnology mRNA Vaccine Product and Services
Table 46. Tiba Biotechnology mRNA Vaccine Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 47. Argos Therapeutics Basic Information, Manufacturing Base and Competitors
Table 48. Argos Therapeutics mRNA Vaccine Major Business
Table 49. Argos Therapeutics mRNA Vaccine Total Revenue (USD Million) (2018-2019)
Table 50. Argos Therapeutics SWOT Analysis
Table 51. Argos Therapeutics mRNA Vaccine Product and Services
Table 52. Argos Therapeutics mRNA Vaccine Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 53. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 54. Sangamo Therapeutics mRNA Vaccine Major Business
Table 55. Sangamo Therapeutics mRNA Vaccine Total Revenue (USD Million) (2018-2019)
Table 56. Sangamo Therapeutics SWOT Analysis
Table 57. Sangamo Therapeutics mRNA Vaccine Product and Services
Table 58. Sangamo Therapeutics mRNA Vaccine Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 59. Ethris Basic Information, Manufacturing Base and Competitors
Table 60. Ethris mRNA Vaccine Major Business
Table 61. Ethris mRNA Vaccine Total Revenue (USD Million) (2018-2019)
Table 62. Ethris SWOT Analysis
Table 63. Ethris mRNA Vaccine Product and Services
Table 64. Ethris mRNA Vaccine Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 65. Global mRNA Vaccine Sales by Manufacturer (2018-2019) (K Doses)
Table 66. Global mRNA Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 67. Key Players mRNA Vaccine Sales in China (2018-2019) (K Doses)
Table 68. Key Players mRNA Vaccine Sales Market Share in China (2018-2019)
Table 69. Key Players Revenue of mRNA Vaccine in China (2018-2019) (USD Million)
Table 70. Global mRNA Vaccine Sales by Regions (2015-2020) (K Doses)
Table 71. Global mRNA Vaccine Sales Market Share by Regions (2015-2020)
Table 72. Global mRNA Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 73. Global mRNA Vaccine Sales and Forecast by Regions (2020-2025) (K Doses)
Table 74. Global mRNA Vaccine Sales Market Share by Regions (2020-2025)
Table 75. Global mRNA Vaccine Revenue and Forecast by Regions (2020-2025) (USD Million)
Table 76. Global mRNA Vaccine Revenue Market Share by Regions (2020-2025) (USD Million)
Table 77. North America mRNA Vaccine Sales by Countries (2015-2020) (K Doses)
Table 78. North America mRNA Vaccine Sales Market Share by Countries (2015-2020)
Table 79. North America mRNA Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 80. North America mRNA Vaccine Revenue Market Share by Countries (2015-2020)
Table 81. North America mRNA Vaccine Sales by Country (2020-2025) (K Doses)
Table 82. North America mRNA Vaccine Sales Market Share by Country (2020-2025)
Table 83. North America mRNA Vaccine Revenue by Country (2020-2025) (USD Million)
Table 84. North America mRNA Vaccine Revenue Market Share by Country (2020-2025)
Table 85. Europe mRNA Vaccine Sales by Countries (2015-2020) (K Doses)
Table 86. Europe mRNA Vaccine Sales Market Share by Countries (2015-2020)
Table 87. Europe mRNA Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 88. Europe mRNA Vaccine Revenue Market Share by Countries (2015-2020)
Table 89. Europe mRNA Vaccine Sales by Country (2020-2025) (K Doses)
Table 90. Europe mRNA Vaccine Sales Market Share by Country (2020-2025)
Table 91. Europe mRNA Vaccine Revenue by Country (2020-2025) (USD Million)
Table 92. Europe mRNA Vaccine Revenue Market Share by Country (2020-2025)
Table 93. Asia-Pacific mRNA Vaccine Sales by Countries (2015-2020) (K Doses)
Table 94. Asia-Pacific mRNA Vaccine Sales Market Share by Countries (2015-2020)
Table 95. Asia-Pacific mRNA Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 96. Asia-Pacific mRNA Vaccine Revenue Market Share by Countries (2015-2020)
Table 97. Asia-Pacific mRNA Vaccine Sales by Country (2020-2025) (K Doses)
Table 98. Asia-Pacific mRNA Vaccine Sales Market Share by Country (2020-2025)
Table 99. Asia-Pacific mRNA Vaccine Revenue by Country (2020-2025) (USD Million)
Table 100. Asia-Pacific mRNA Vaccine Revenue Market Share by Country (2020-2025)
Table 101. South America mRNA Vaccine Sales by Countries (2015-2020) (K Doses)
Table 102. South America mRNA Vaccine Sales Market Share by Countries (2015-2020)
Table 103. South America mRNA Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 104. South America mRNA Vaccine Revenue Market Share by Countries (2015-2020)
Table 105. South America mRNA Vaccine Sales by Country (2020-2025) (K Doses)
Table 106. South America mRNA Vaccine Sales Market Share by Country (2020-2025)
Table 107. South America mRNA Vaccine Revenue by Country (2020-2025) (USD Million)
Table 108. South America mRNA Vaccine Revenue Market Share by Country (2020-2025)
Table 109. Middle East & Africa mRNA Vaccine Sales by Countries (2015-2020) (K Doses)
Table 110. Middle East & Africa mRNA Vaccine Sales Market Share by Countries (2015-2020)
Table 111. Middle East & Africa mRNA Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 112. Middle East & Africa mRNA Vaccine Revenue Market Share by Countries (2015-2020)
Table 113. Middle East & Africa mRNA Vaccine Sales by Country (2020-2025) (K Doses)
Table 114. Middle East & Africa mRNA Vaccine Sales Market Share by Country (2020-2025)
Table 115. Middle East & Africa mRNA Vaccine Revenue by Country (2020-2025) (USD Million)
Table 116. Middle East & Africa mRNA Vaccine Revenue Market Share by Country (2020-2025)
Table 117. China mRNA Vaccine Sales by Type (2015-2020) (K Doses)
Table 118. China mRNA Vaccine Sales Market Share by Type (2015-2020)
Table 119. China mRNA Vaccine Revenue by Type (2015-2020) (USD Million)
Table 120. China mRNA Vaccine Revenue Market Share by Type (2015-2020)
Table 121. China mRNA Vaccine Sales by Type (2020-2025) (K Doses)
Table 122. China mRNA Vaccine Sales Market Share by Type (2020-2025)
Table 123. China mRNA Vaccine Revenue by Type (2020-2025) (USD Million)
Table 124. China mRNA Vaccine Revenue Market Share by Type (2020-2025)
Table 125. Global mRNA Vaccine Sales by Application (2015-2020) (K Doses)
Table 126. Global mRNA Vaccine Sales Market Share by Application (2015-2020)
Table 127. Global mRNA Vaccine Revenue by Application (2015-2020) (USD Million)
Table 128. Global mRNA Vaccine Revenue Market Share by Application (2015-2020)
Table 129. Global mRNA Vaccine Price by Application (2015-2020) (USD/Dose)
Table 130. Global mRNA Vaccine Sales by Application (2020-2025) (K Doses)
Table 131. Global mRNA Vaccine Sales Market Share by Application (2020-2025)
Table 132. Global mRNA Vaccine Revenue by Application (2020-2025) (USD Million)
Table 133. Global mRNA Vaccine Revenue Market Share by Application (2020-2025)
Table 134. Global mRNA Vaccine Price by Application (2020-2025) (USD/Dose)
Table 135. China mRNA Vaccine Sales by Application (2015-2020) (K Doses)
Table 136. China mRNA Vaccine Sales Market Share by Application (2015-2020)
Table 137. China mRNA Vaccine Revenue by Application (2015-2020) (USD Million)
Table 138. China mRNA Vaccine Revenue Market Share by Application (2015-2020)
Table 139. China mRNA Vaccine Sales by Application (2020-2025) (K Doses)
Table 140. China mRNA Vaccine Sales Market Share by Application (2020-2025)
Table 141. China mRNA Vaccine Revenue by Application (2020-2025) (USD Million)
Table 142. China mRNA Vaccine Revenue Market Share by Application (2020-2025)
Table 143. Direct Channel Pros & Cons
Table 144. Indirect Channel Pros & Cons
Table 145. Distributors/Traders/ Dealers List
Table 146. Customers of mRNA Vaccine
Table 147. Market Opportunities in Next Few Years
Table 148. Market Risks Analysis
Table 149. Market Drivers
List of Figures
Figure 1. mRNA Vaccine Picture
Figure 2. Global mRNA Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Standardization Of Cancer Treatment MRNA Vaccine Picture
Figure 4. Individualized Cancer Treatment MRNA Vaccine Picture
Figure 5. Infectious Disease Treatment MRNA Vaccine Picture
Figure 6. Infection Prevention MRNA Vaccine Picture
Figure 7. mRNA Vaccine Sales Market Share by Application in 2019
Figure 8. Infectious Disease Picture
Figure 9. Cancer Picture
Figure 10. Other Picture
Figure 11. Global mRNA Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 12. Global mRNA Vaccine Sales Growth Rate (2015-2025) (K Doses)
Figure 13. Global mRNA Vaccine Sales Market Share by Manufacturer in 2019
Figure 14. Global mRNA Vaccine Revenue Market Share by Manufacturer in 2019
Figure 15. Key Players mRNA Vaccine Revenue Market Share in China in 2019
Figure 16. Global Top 5 mRNA Vaccine Manufacturer Market Share in 2019
Figure 17. Top 3 mRNA Vaccine Players Market Share in China in 2019
Figure 18. Global mRNA Vaccine Revenue Market Share by Regions in 2019
Figure 19. North America mRNA Vaccine Sales YoY Growth (2015-2025) (K Doses)
Figure 20. North America mRNA Vaccine Revenue YoY Growth (2015-2025) (USD Million)
Figure 21. Europe mRNA Vaccine Sales YoY Growth (2015-2020) (K Doses)
Figure 22. Europe mRNA Vaccine Revenue YoY Growth (2015-2020) (USD Million)
Figure 23. Asia-Pacific mRNA Vaccine Sales YoY Growth (2015-2020) (K Doses)
Figure 24. Asia-Pacific mRNA Vaccine Revenue YoY Growth (2015-2020) (USD Million)
Figure 25. South America mRNA Vaccine Sales YoY Growth (2015-2020) (K Doses)
Figure 26. South America mRNA Vaccine Revenue YoY Growth (2015-2020) (USD Million)
Figure 27. Middle East & Africa mRNA Vaccine Sales YoY Growth (2015-2020) (K Doses)
Figure 28. Middle East & Africa mRNA Vaccine Revenue YoY Growth (2015-2020) (USD Million)
Figure 29. North America mRNA Vaccine Sales Market Share by Country in 2019
Figure 30. North America mRNA Vaccine Revenue Market Share by Country in 2019
Figure 31. United States mRNA Vaccine Market Size and Growth Rate (2015-2025) (USD Million)
Figure 32. Canada mRNA Vaccine Market Size and Growth Rate (2015-2025) (USD Million)
Figure 33. Mexico mRNA Vaccine Market Size and Growth Rate (2015-2020) (USD Million)
Figure 34. Europe mRNA Vaccine Revenue Market Share by Country in 2019
Figure 35. Germany mRNA Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 36. United Kingdom mRNA Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 37. France mRNA Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 38. Russia mRNA Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 39. Italy mRNA Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 40. Asia-Pacific mRNA Vaccine Sales Market Share by Region 2018
Figure 41. Asia-Pacific mRNA Vaccine Revenue Market Share by Region 2018
Figure 42. China mRNA Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 43. Japan mRNA Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 44. Korea mRNA Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 45. India mRNA Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 46. Southeast Asia mRNA Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 47. Australia mRNA Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 48. South America mRNA Vaccine Sales Market Share by Country in 2019
Figure 49. South America mRNA Vaccine Revenue Market Share by Country in 2019
Figure 50. Brazil mRNA Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 51. Argentina mRNA Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 52. Saudi Arabia mRNA Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 53. Turkey mRNA Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 54. Egypt mRNA Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 55. South Africa mRNA Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 56. Global Revenue Market Share of mRNA Vaccine by Type in 2019
Figure 57. Global Revenue Market Share of mRNA Vaccine by Application in 2019
Figure 58. Sales Channel: Direct Channel vs Indirect Channel
Please feel free to write an email to us or to use our electronic ticketing system.
